In addition, genes representing the programmed cell death-1 and programmed cell death ligand-1 (PD-1/PD-L1) cancer immunotherapy, T cell exhaustion signaling, and tumor microenvironment pathways were significantly associated with the TME. The gene discussed is PDCD1; the disease is neoplasm.